A
The startup develops a suite of in-vitro diagnostics utilizing an ultra-sensitive optical reporter platform to enable early detection of pancreatic cancer. Their technology provides healthcare professionals with a multi-omics diagnostic approach, requiring only a single sample and operating on one instrument, supported by published clinical evidence.
Updated 2 months ago
Funding
$9.9M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops a suite of in-vitro diagnostics utilizing an ultra-sensitive optical reporter platform to enable early detection of pancreatic cancer. Their technology provides healthcare professionals with a multi-omics diagnostic approach, requiring only a single sample and operating on one instrument, supported by published clinical evidence.